Key statistics
As of last trade IGM Biosciences Inc (1K0:FRA) traded at 14.00, -12.50% below its 52-week high of 16.00, set on Feb 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.00 |
---|---|
High | 14.00 |
Low | 14.00 |
Bid | 13.90 |
Offer | 14.20 |
Previous close | 13.50 |
Average volume | 95.00 |
---|---|
Shares outstanding | 59.32m |
Free float | 22.16m |
P/E (TTM) | -- |
Market cap | 914.10m USD |
EPS (TTM) | -3.67 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:39 BST.
More ▼
Announcements
- IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
- IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Jefferies Healthcare Conference
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
More ▼